Skip to main content
Log in

Prostatastanzbiopsie unter Diclofenac

Signifikante Schmerzreduktion und Verbesserung der Patientenakzeptanz

Diclofenac during prostate needle biopsy

Significant pain reduction

  • Originalien
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Ziel der prospektiv randomisierten Studie war, die Effizienz von Diclofenac als Schmerzmedikation bei der Prostatabiopsie zu überprüfen.

Material und Methoden

228 Patienten wurden eingeschlossen. In Gruppe 1 (n=80) erfolgte die Biopsie nach Lidocain-Gel-Instillation, Gruppe 2 (n=72) erhielt zusätzlich ein Placebosuppositorium (Supp.) und Gruppe 3 (n=76) 50 mg Diclofenac-Supp. Nach der Biopsie bestimmten die Patienten ihren Schmerzscore (VAS=10) und nach 14 Tagen erfolgte eine telefonische Verlaufsbefragung.

Ergebnisse

Patienten der Verumgruppe wiesen signifikant niedrigere Schmerzwerte auf als Patienten der Kontroll- oder der Placebogruppe. Eine erneute Biopsie unter gleichen Bedingungen lehnten 25% der Patienten der Kontroll- und 34% der Placebogruppe, dagegen nur 11% der Verumgruppe ab (p<0,05).

Schlussfolgerung

Diclofenac steigert die Akzeptanz der Stanzbiopsie und stellt eine suffiziente, nicht-invasive analgetische Alternative zur periprostatischen Infiltration dar.

Abstract

Background

The aim of this study was to evaluate the efficacy of diclofenac to reduce pain during prostate biopsy.

Methods

After prospective randomization all patients received an intrarectal lidocaine gel instillation. Group 1 (n=80) functioned as control group, group 2 (n=72) received a placebo, and group 3 (n=76) a 50 mg diclofenac suppository in addition. Patients were asked to identify their pain score (VAS 10) after the biopsy. Two weeks later, the patients were called and asked about the post-biopsy course.

Results

Patients in the diclofenac group had significantly lower pain scores than control or placebo group patients. Another biopsy without additional anesthesia was refused by 25% of the control group and 34% of the placebo group, but only by 11% of the diclofenac group (p<0.05).

Conclusions

The preinterventional administration of diclofenac suppositories is a simple but efficient procedure for pain reduction in patients who undergo prostate biopsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Alavi AS, Soloway MS, Vaidya A, Lynne CM, Gheiler EL (2001) Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing two methods. J Urol 166: 1343–1345

    Article  PubMed  Google Scholar 

  2. Berger AP, Frauscher F, Halpern EJ, Spranger R, Steiner H, Bartsch G, Horninger W (2003) Periprostatic administration of local anesthesia during transrectal ultrasound-guided biopsy of the prostate: a randomized, double-blind, placebo-controlled study. Urology 61(3): 585–588

    Article  PubMed  Google Scholar 

  3. Djavan B, Remzi M, Marberger M (2003) When to biopsy and when to stop biopsying. Urol Clin North Am 30: 252–262

    Article  Google Scholar 

  4. Haq A, Patel HR, Habib MR, Donaldson PJ, Parry JR (2004) Diclofenac suppository analgesia for transrectal ultrasound guided biopsies of the prostate: a double-blind, randomized controled trial. J Urol 171: 1489–1491

    Article  PubMed  Google Scholar 

  5. Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142: 71–75

    PubMed  Google Scholar 

  6. Irani J, Fournier F, Bon D, Gremmo E, Doré B, Aubert J (1997) Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. Br J Urol 79: 608–610

    PubMed  Google Scholar 

  7. Kantor TG (1992) NSAIDs, Salicylates and Blood Coagulation. In: Famaey JP, Paulus HE (ed) Therapeutic applications of NSAIDs. Marcel Dekker, New York, pp 265–277

  8. Levine MA, Ittmann M, Melamed J, Lepor H (1998) Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159: 475–476

    Article  Google Scholar 

  9. Palisaar J, Eggert T, Graefen M, Haese A, Huland H (2003) Ultraschallgesteuerte transrektale Prostatabiopsien. Urologe A 42: 1188–1195

    Article  PubMed  Google Scholar 

  10. Pareek G, Armenakas NA, Fracchia JA (2001) Periprostatic nerve blockade for transrectal ultrasound guided biopsy of the prostate: A randomized, bouble-blind, placebo-controlled study. J Urol 166: 894–897

    Article  PubMed  Google Scholar 

  11. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K (2000) The optimal systemic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 163: 163–167

    Article  PubMed  Google Scholar 

  12. Rabets JC, Jones JS, Patel AR, Zippe CD (2004) Bupivacaine provides rapid, effective prostatic anesthesia for transrectal prostate biopsy. BJU 93: 1216–1217

    Article  Google Scholar 

  13. Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45: 2–12

    Article  PubMed  Google Scholar 

  14. Zisman A, Leibovichi D, Kleinmann J, Siegel YI, Lindner A (2001) The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol 165: 445–454

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Bach.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bach, T., Tauber, R. Prostatastanzbiopsie unter Diclofenac. Urologe 45, 343–346 (2006). https://doi.org/10.1007/s00120-005-0984-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-005-0984-4

Schlüsselwörter

Keywords

Navigation